Your browser doesn't support javascript.
loading
Real-world effect of bevacizumab and eribulin on metastatic breast cancer using a propensity score matching analysis.
Matsui, Koshi; Earashi, Mitsuharu; Yoshikawa, Akemi; Fukushima, Wataru; Nozaki, Zensei; Oyama, Kaeko; Maeda, Kiichi; Nakakura, Akiyoshi; Morita, Satoshi; Fujii, Tsutomu.
Afiliação
  • Matsui K; Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
  • Earashi M; Department of Surgery, Toyama Nishi General Hospital, Toyama 939-2716, Japan.
  • Yoshikawa A; Department of Surgery, Toyama Prefectural Central Hospital, Toyama 930-8550, Japan.
  • Fukushima W; Department of Surgery, Takaoka City Hospital, Takaoka, Toyama 933-8550, Japan.
  • Nozaki Z; Department of Surgery, Tonami General Hospital, Tonami, Toyama 939-1395, Japan.
  • Oyama K; Department of Surgery, Kouseiren Takaoka Hospital, Takaoka, Toyama 933-8555, Japan.
  • Maeda K; Department of Surgery, Toyama Prefectural Central Hospital, Toyama 930-8550, Japan.
  • Nakakura A; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto 606-8501, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto 606-8501, Japan.
  • Fujii T; Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Mol Clin Oncol ; 18(2): 12, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36761387

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2023 Tipo de documento: Article